Clinical Trial Update: A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating SYHX2011 versus paclitaxel for advanced breast cancer is ongoing, with no current status reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Paclitaxel for Injection (Albumin-bound) (Paclitaxel (Albumin-bound))
• SYHX2011

Snippet

Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd. | Conditions: Advanced Breast Cancer | Phase 3 | Status: UNKNOWN